Polyrizon Completes Clinical Site Network for NASARIX™ Study and Advances Toward Patient Enrollment
Go back to Polyrizon Completes Clinical Site Network for NASARIX™ Study and Advances Toward Patient Enrollment| (NASDAQ: PLRZ) | Delayed: 11.03 +0.38 (3.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.65 | 52 Week High | $ | |||
| Open | $11.60 | 52 Week Low | $ | |||
| Day High | $11.60 | P/E | N/A | |||
| Day Low | $9.15 | EPS | $ | |||
| Volume | 159,436 | |||||
